Teva director Jean-Michel Halfon resigns from board, effective May 8, 2023

TEVA PHARMACEUTICAL INDUSTRIES LTD

Jean-Michel Halfon resigned immediately on May 8, 2023, citing personal reasons.
He served as a director since 2014, chairing the HR/Compensation and Compliance Committees.
Halfon was not standing for re-election at Teva's June 15, 2023 annual meeting; no disagreements with Teva.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jean-Michel Halfon

Director

TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective: 2023-05-08
Filed: May 11, 2023, 7:59 PM ET

On May 8, 2023, Jean-Michel Halfon informed Teva Pharmaceutical Industries Ltd. (“Teva”) that in light of personal reasons, he will resign from Teva’s Board of Directors (“Board”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jean-Michel Halfon resigned as Director at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action: resigned
Role: Director

Exact text from the filing

On May 8, 2023, Jean-Michel Halfon informed Teva Pharmaceutical Industries Ltd. (“Teva”) that in light of personal reasons, he will resign from Teva’s Board of Directors (“Board”), effective immediately.

View on SEC.gov

TEVA PHARMACEUTICAL INDUSTRIES LTD filing history →

Source: SEC EDGAR

accession 0001193125-23-141992

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.